Kalender Press & nyheter Investor relations Jobb Läkemedel Biopharmaceuticals Partnerskap FoU Om oss Calendar Press and news Investor relations Jobs Products Biopharmaceuticals Partnering R&D About us Sök Kontakt .com Hem Ordlista .se home contact glossary search


contact.
Picture of Peter Edman

Peter Edman
Vice President, Chief Scientific Officer and Head of Research & Development

 

E-mail

+46 8 697 21 77




We develop new medications, from drug discovery to patient
 

When developing our products, we have expertise in all areas of preclinical and clinical trials. Our experience in and knowledge of documentation requirements from regulatory authorities enable us to submit an application to register a new drug in a professional manner. This is essential to be able to take specialist drugs all the way to market and thus to patients with large medical needs.
 

We at Biovitrum have extensive experience in the development of protein pharmaceuticals.
 

Biologics are often produced via cell culture and therefore require substantial knowledge of cellular biology and biotechnology. Our strength rests on our employees’ lengthy experience of drug and process development, our innovative culture, and our strong finances.







Peter Edman
Picture of Peter Edman

“Innovative research and experience from the development of pharmaceuticals are key factors in Biovitrums business. In line with our strategy we are now focusing on specialist pharmaceuticals with several projects in clinical phases.

 

A positive development of our projects secures our continued position as a successful specialist pharmaceutical company.”

 

Peter Edman, Vice President, Chief Scientific Officer and Head of Research & Development


 

Facts

Development of pharmaceuticals demands extensive evaluation of a chosen protein in biological models and patient studies.
Methods and result are documented in accordance to requirements from authorities.